Clinical Trials on Multiple Primary Cancers in United Kingdom

Total 45554 results

Royal Marsden NHS Foundation Trust
Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Institute... and other collaborators

Recruiting

AI & Radiomics for Stratification of Lung Nodules After Radically Treated Cancer (AI-SONAR)

Lung Cancer | Lung Metastases | Indeterminate Pulmonary Nodules | Second Primary Cancer

United Kingdom
Queen Mary University of London
Takeda Pharmaceuticals International, Inc.

Recruiting

SIZOMUS Safety of Ixazomib Targeting Plasma Cells in Multiple Sclerosis (SIZOMUS)

Relapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple Sclerosis

United Kingdom
M.D. Anderson Cancer Center

Completed

Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During an Outpatient Palliative Care Visit

Advanced Cancer | Malignant Neoplasms of Independent (Primary) Multiple Sites

United States
Imperial College London
GlaxoSmithKline; University College, London; Medical Research Council; Queen Mary... and other collaborators

Completed

Patient Research Cohort: Rapidly Evolving Multiple Sclerosis (PRC-REMS)

Relapsing-remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis

United Kingdom
Perspectum

Recruiting

Research and Development of Novel Quantitative Magnetic Resonance Imaging (MRI) Techniques in a Single Scan for Multiple Organ Application (RADIUS)

Multiple

United Kingdom
Mitsubishi Tanabe Pharma Corporation

Completed

Comparative Oral Bioavailability Study of MT-1303

Relapsing-remitting Multiple Sclerosis

United Kingdom
Mitsubishi Tanabe Pharma Corporation

Completed

A Phase 1 Study to Explore the Cardiac Pharmacodynamics of MT-1303

Relapsing-remitting Multiple Sclerosis

United Kingdom
The Leeds Teaching Hospitals NHS Trust

Active, not recruiting

FIT Study (Functional Outcomes In Trauma Study)

Wounds and Injuries | Surgery | Rehabilitation | Orthopedic Disorder | Patient Reported Outcome Measures | Disability Evaluation | Recovery of Function | Multiple Trauma/Injuries | Trauma Centers | Trauma Severity Indices | Advanced Trauma Life Support Care

United Kingdom
University of Glasgow
NHS Ayrshire and Arran; AKM

Completed

The Effect of High Intensity Interval Training on Cardiovascular Fitness in People With Progressive Multiple Sclerosis.

Multiple Sclerosis, Progressive

United Kingdom
Mitsubishi Tanabe Pharma Corporation

Completed

Mass Balance Study of MT-1303

Relapsing-remitting Multiple Sclerosis

United Kingdom
John Carroll University
University Hospital Southampton NHS Foundation Trust

Active, not recruiting

Development and Validation of an Online Neurobehavioral Evaluation Tool for PTEN Patients

PTEN Hamartoma Tumor Syndrome

United States, United Kingdom
Oxford University Hospitals NHS Trust
Gleamer

Recruiting

AI Assisted Detection of Fractures on X-Rays (FRACT-AI) (FRACT-AI)

Fractures, Closed | Fracture | Fractures, Open | Bone Fracture | Dislocation | Fracture Multiple

United Kingdom
University of Lincoln
Nottingham University Hospitals NHS Trust

Completed

Behavioural Activation for Low Mood in Multiple Sclerosis (BALMS)

Depression | Secondary-progressive Multiple Sclerosis

United Kingdom
University of Leicester
Zimmer Biomet; British Heart Foundation; National Health Service, United Kingdom

Withdrawn

Red Cell Rejuvenation for the Attenuation of Transfusion Associated Organ Injury in Cardiac Surgery

Sepsis | Inflammation | Organ Failure, Multiple

United Kingdom
Astellas Pharma Europe B.V.

Completed

A Study to Evaluate How Tamsulosin (at 1 Dose) and Solifenacin (at 2 Different Doses) Are Taken up From the Intestine, Distributed Through the Body and Eliminated From the Body When Administered in Combination as a Single Tablet (Called EC905)

Healthy Subjects | Pharmacokinetics | EC905 | Multiple Dose

United Kingdom
Cambridge University Hospitals NHS Foundation Trust
University of Cambridge

Recruiting

CCMR Two: A Phase IIa, Randomised, Double-blind, Placebo-controlled Trial of the Ability of the Combination of Metformin and Clemastine to Promote Remyelination in People With Relapsing-remitting Multiple Sclerosis Already on Disease-modifying Therapy

Multiple Sclerosis

United Kingdom
University of Hull

Active, not recruiting

Socioeconomic Inequalities in the Diagnosis and Treatment of Colon and Ovarian Cancer in England Between 2016-2017

Diagnoses Disease | Treatment Related Cancer | Equality, Gender

United Kingdom
North Bristol NHS Trust
University of Nottingham; Medical Research Council; University of Bristol; Bristol... and other collaborators

Unknown

Assessment of Bone Marrow-derived Cellular Therapy in Progressive Multiple Sclerosis (ACTiMuS) (ACTiMuS)

Progressive Multiple Sclerosis

United Kingdom
University of Glasgow
NHS Ayrshire and Arran; AKM

Completed

Access, Use and Opinions of Physiotherapy and Rehabilitation Services of People With Progressive MS in the UK.

Progressive Multiple Sclerosis

United Kingdom
NHS Greater Glasgow and Clyde
Biogen

Enrolling by invitation

Multiple Sclerosis Outcome Determination Evaluating Real Differences After TimE (MODERATE)

Relapsing Remitting Multiple Sclerosis

United Kingdom
Glasgow Caledonian University

Unknown

Exercise to Manage Fatigue in Progressive Multiple Sclerosis

Multiple Sclerosis

United Kingdom
Oxford University Hospitals NHS Trust

Completed

A Feasibility Study to Assess Pre Admission Status and Six Month Outcomes After Major Trauma

Multiple Trauma

United Kingdom
Queen Mary University of London
Merck Sharp & Dohme LLC

Completed

Raltegravir (Isentress) Pilot Study in Relapsing Multiple Sclerosis (INSPIRE)

Relapsing Remitting Multiple Sclerosis

United Kingdom
Barts & The London NHS Trust

Completed

Pre-Hospital Zone 1 Partial Resuscitative Endovascular Balloon Occlusion of the Aorta for Injured Patients With Exsanguinating Sub-diaphragmatic Haemorrhage (P-PRO)

Emergencies | Trauma Injury | Trauma, Multiple

United Kingdom
Intuitive Surgical

Active, not recruiting

Assessment of Tool Placement in Pulmonary Nodule(s) Using a Robotic Navigational Bronchoscopy System

Lung Cancer

United Kingdom
University of Oxford
Oxford University Hospitals NHS Trust

Recruiting

MotIoN aDaptive Deep Brain Stimulation for MSA (MINDS)

MSA - Multiple System Atrophy

United Kingdom
University College London Hospitals

Completed

A Randomised Controlled Trial of Neuroprotection With Lamotrigine in Secondary Progressive Multiple Sclerosis

Secondary Progressive Multiple Sclerosis

United Kingdom
Royal Marsden NHS Foundation Trust
King's College Hospital NHS Trust; University College London Hospitals; Guy's... and other collaborators

Recruiting

Lung Nodule Imaging Biobank for Radiomics and AI Research (LIBRA)

Lung Neoplasms | Lung Cancer | Pulmonary Nodule, Solitary | Pulmonary Nodule, Multiple

United Kingdom
Northumbria University

Completed

Brief Physical Activity Intervention for Older People With Multimorbidity

Old Age; Debility | Physical Inactivity | Chronic Conditions, Multiple

United Kingdom
University College, London
National Multiple Sclerosis Society

Completed

Simvastatin in Secondary Progressive Multiple Sclerosis (MS-OPT)

Secondary Progressive Multiple Sclerosis

United Kingdom
University of Nottingham
Nottingham University Hospitals NHS Trust

Completed

Acceptance Based Telephone Support When Transitioning to SPMS (AT-SPMS)

Secondary Progressive Multiple Sclerosis

United Kingdom
Nottingham University Hospitals NHS Trust
Optellum Ltd.

Recruiting

DOLCE: Determining the Impact of Optellum's Lung Cancer Prediction Solution (DOLCE)

Lung Cancer | Pulmonary Nodule, Solitary | Pulmonary Nodule, Multiple | AI (Artificial Intelligence)

United Kingdom
Daval International Limited

Unknown

AIMSPRO in the Treatment of Bladder Dysfunction in Secondary Progressive Multiple Sclerosis

Secondary Progressive Multiple Sclerosis

United Kingdom
Imperial College London
Merck Sharp & Dohme LLC

Active, not recruiting

Trial of Pembrolizumab in Cancer of Unknown Primary (CUPem)

Cancer of Unknown Primary Site

United Kingdom
Royal Marsden NHS Foundation Trust

Recruiting

Inherited Cancer Early Diagnosis (ICED) Study (ICED)

Lynch Syndrome | Familial Adenomatous Polyposis | Hereditary Diffuse Gastric Cancer | Peutz-Jeghers Syndrome | Cowden Syndrome | Li Fraumeni Syndrome | MutYH-associated Polyposis | SMAD4 Gene Mutation

United Kingdom
University College, London
UCLH

Unknown

D-mannose for the Prevention of UTIs in Multiple Sclerosis

Multiple Sclerosis | Recurrent Urinary Tract Infections

United Kingdom
Royal Marsden NHS Foundation Trust
Institute of Cancer Research, United Kingdom; Verastem, Inc.; Chugai Pharmaceutical

Recruiting

Phase I Trial of VS-6766 Alone and in Combination With Everolimus (RAF/MEK)

Multiple Myeloma | Ovarian Cancer | Lung Cancer | Solid Tumours

United Kingdom
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...
Merck Serono Limited, an affiliate of Merck KGaA, Darmstadt, Germany

Completed

Effectiveness of Cladribine Tablets in Participants With Highly-active Relapsing Multiple Sclerosis (CAMELOT-MS)

Relapsing-Remitting Multiple Sclerosis

United Kingdom
GlaxoSmithKline

Terminated

A First Time in Human Study Exploring Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2618960 in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis (RRMS)

Multiple Sclerosis, Relapsing-Remitting

United Kingdom
University of Oxford
Optellum Ltd.

Completed

IDEAL: Artificial Intelligence and Big Data for Early Lung Cancer Diagnosis Study (IDEAL)

Lung Cancer | Pulmonary Nodule, Solitary | Pulmonary Nodule, Multiple

United Kingdom
University College, London

Completed

Transcutaneous Tibial Nerve Stimulation of Patients With Overactive Bladder (OAB) Syndrome

Multiple Sclerosis | Overactive Bladder

United Kingdom
University of Oxford
Mayo Clinic; University of California, San Francisco; Surrey Sleep Research Centre...

Completed

Manipulating and Optimising Brain Rhythms for Enhancement of Sleep (MORPHEUS)

Epilepsy | Chronic Pain | Parkinson Disease | MSA - Multiple System Atrophy

United Kingdom
Royal Marsden NHS Foundation Trust
Merck Sharp & Dohme LLC; Institute of Cancer Research, United Kingdom; National...

Recruiting

Pembrolizumab in Muscle Invasive/Metastatic Bladder Cancer (PLUMMB)

Invasive Bladder Cancer

United Kingdom
Trio Medicines Ltd.
Biogen

Completed

Avonex®: Safety, Blood Levels and Effects (C-851)

Multiple Sclerosis (MS)

United Kingdom
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Prospective Trial of Vaccine Responses in Childhood Cancer Survivors

Childhood Cancer | Multiple Diseases

United States
University of Nottingham
National Multiple Sclerosis Society

Completed

Worms for Immune Regulation of Multiple Sclerosis (WIRMS)

Multiple Sclerosis, Relapsing-Remitting

United Kingdom
Sheffield Teaching Hospitals NHS Foundation Trust
University of Sheffield; Nottingham Trent University; Sheffield Hospitals Charity

Recruiting

Biomarkers of aHSCT (BIO-MS)

Multiple Sclerosis, Relapsing-Remitting

United Kingdom
Viralytics

Completed

CAVATAK (CVA21) in Non-muscle Invasive Bladder Cancer (VLA-012 CANON) (CANON)

Non-muscle Invasive Bladder Cancer

United Kingdom
Jazz Pharmaceuticals

Completed

A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple Sclerosis

Multiple Sclerosis | Detrusor Overactivity

United Kingdom
Novartis Pharmaceuticals

Completed

A Phase I/II Study of BEZ235 in Patients With Advanced Solid Malignancies Enriched by Patients With Advanced Breast Cancer

Breast Cancer | Advanced Solid Tumors | Cowden Syndrome

Netherlands, Spain, Germany, United Kingdom, United States

Clinical Trials on Multiple Primary Cancers in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations